Slovakia will halt its rollout of AstraZeneca’s Covid-19 vaccine for folks being given their first doses, its Well being Ministry has stated, after an inquiry into the loss of life of an individual who suffered blood clots after receiving the jab.
The loss of life of a 47-year-old lady was doubtless related to her receiving the Anglo-Swedish vaccine, resulting from a medical predisposition she had for blood clotting problems, the nation’s regulator, the State Institute for Drug Management (SUKL) stated final week.
“At present, people who find themselves ready for the second dose … are [still] being vaccinated with the AstraZeneca vaccine,” Well being Ministry spokesperson Zuzana Eliasova stated on Tuesday.
She added that the ministry was contemplating a number of options for its ongoing Covid-19 vaccination marketing campaign, with the following steps to be introduced later this week.
SUKL stated final week that an post-mortem had discovered that the girl had suffered cerebral venous sinus thrombosis – blood clotting stopping blood draining from the mind.
An affiliation between her vaccination and the blood clots was thought of “doubtless” due to her “genetic predisposition to a thrombophilic state,” the institute defined in a press release.
Various different European international locations have additionally reported circumstances of blood clots in folks given AstraZeneca’s Covid-19 vaccine, leading to its use being suspended or restricted to sure age teams.
The European Medicines Company has stated that “uncommon blood clots with low blood platelets must be listed as very uncommon negative effects of Vaxzevria,” however, general, the jab’s advantages outweigh the dangers.
Suppose your pals would have an interest? Share this story!